WO2026030242 - ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR THE TREATMENT OF FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
National phase entry is expected:
Publication Number
WO/2026/030242
Publication Date
05.02.2026
International Application No.
PCT/US2025/039526
International Filing Date
28.07.2025
Title **
[English]
ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR THE TREATMENT OF FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
[French]
COMPOSITIONS DE VIRUS ADÉNO-ASSOCIÉS POUR LE TRAITEMENT DE LA DYSTROPHIE MUSCULAIRE FACIO-SCAPULO-HUMÉRALE
Applicants **
KATE THERAPEUTICS, INC.
Inventors
SESHADRI, Saurav
TABEBORDBAR, Sharif
TABEBORDBAR, Shayan
YE, Simon
Priority Data
63/676,790
29.07.2024
US
63/687,992
28.08.2024
US
63/788,362
14.04.2025
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 6280 | |
| EPO | Filing, Examination, Granting | 91410 | |
| Japan | Filing, Examination, Granting | 4691 | |
| South Korea | Filing, Examination, Granting | 7079 | |
| USA | Filing, Examination, Granting | 22940 |
Total:
132,400
Contact Us
Abstract[English]
The present invention provides novel gene therapy compositions for use in treatment of facioscapulohumeral muscular dystrophy (FSHD).[French]
La présente invention concerne de nouvelles compositions de thérapie génique destinées à être utilisées dans le traitement de la dystrophie musculaire facio-scapulo-humérale (FSHD).